A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects

Completed · Phase 1

Conditions studied: Peanut Allergy

In brief

The study aims to assess the biological potency of the In-House Reference Preparation (IHRP) of peanut allergens extract by a quantitative Skin Prick Test (SPT) method in peanut-allergic subjects.

Key facts

Study ID

NCT03352726

Run by

DBV Technologies

People needed

27

Starts

2017-11-24

Expected to finish

2018-06-29

Last updated by the study team

2019-07-26

Who can join

Age: 12 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States
• Children's Hospital Colorado — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.